Side-by-side financials for ENTA and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ENTA | NVS |
|---|---|---|
| Market cap | - | $292.08 B |
| US-listed rank | - | #47 |
| Revenue (latest FY) | $65.32M | - |
| Net income (latest FY) | -$81.89M | - |
| Net margin | -125.4% | - |
| SEC filings | 822 | 947 |
Full pages: ENANTA PHARMACEUTICALS INC and Novartis AG, or browse the full rankings.